Article citationsMore>>

Liu, Y., Zhang, B., Zhou, Y., Xing, Y., Wang, Y., Jia, Y., et al. (2023) Targeting Hippo Pathway: A Novel Strategy for Helicobacter pylori-Induced Gastric Cancer Treatment. Biomedicine & Pharmacotherapy, 161, Article 114549.
https://doi.org/10.1016/j.biopha.2023.114549

has been cited by the following article:

• TITLE: The Regulatory Mechanism and Therapeutic Targets of the HIPPO Pathway in Helicobacter pylori-Associated Gastric Cancer

  AUTHORS: Hao Tan, Ping Lu

  KEYWORDS: Helicobacter pylori, Gastric Cancer, HIPPO Pathway, YAP/TAZ, CagA

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.9, September 3, 2025

  ABSTRACT: The HIPPO signaling pathway critically regulates cell proliferation, apoptosis, and tissue homeostasis, playing a pivotal role in Helicobacter pylori (H. pylori)-associated gastric cancer, a major contributor to the global gastric cancer burden. Dysregulation of HIPPO signaling, particularly through YAP/TAZ activation, drives tumorigenesis, invasion, and metastasis in H. pylori-infected gastric tissues. This review elucidates the molecular mechanisms by which H. pylori virulence factors, such as CagA, disrupt HIPPO pathway components, including MST1/2 and LATS1/2 kinases, and explores epigenetic and pathway crosstalk mechanisms. We also discuss promising therapeutic targets, including YAP/TAZ inhibitors and combination strategies with H. pylori eradication therapies. These insights aim to guide the development of targeted interventions for H. pylori-related gastric malignancies.